VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 520 participants.

Also called NCT07516444

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 520 participants (planned count) (from the registry)
Sponsor
VDyne, Inc. (from the registry)
Registry
  • NCT NCT07516444
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07516444. Randomized; single masking; primary purpose treatment. Start 2026-07-28 (actual); primary completion 2029-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Acronym
TRIVITA
Condition
Tricuspid Valve Regurgitation
Condition
Tricuspid Valve Disease
Condition
Cardiovascular Diseases (CVD)
Condition
Heart Valve Diseases
Condition
Tricuspid Valve Insufficiency
Condition
Severe Heart Valve Disease
Condition
Symptomatic Tricuspid Regurgitation
Intervention (Device)
Transcatheter Tricuspid Valve Replacement (TTVR) with VDyne TriNova System
Intervention (Device)
Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE System
Lead sponsor
VDyne, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07516444
Content hash
4e3463bbbf872723b1285518800b04a6f458f204523e9d149b89f233c188d073